Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525731 · ClinicalTrials.gov registry record
Targeting Effective Analgesia in Clinics for HIV - Patient Cohort
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 170
- Enrollment target
NCT02525731: Completed study, sponsored by Boston Medical Center.
NCT02525731 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 170 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02525731 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The TEACH patient cohort will characterize a clinic sample of HIV-infected patients on chronic opioid therapy (COT) by describing basic demographics and health status, including characteristics of pain (severity and interference), aberrant behaviors/misuse of COT, substance use and trust/satisfaction with providers. In addition, data on a subset of participants will be used to supplement analysis of secondary outcomes for the TEACH randomized controlled trial (RCT), an intervention study directed at COT providers (outlined in a separate Clinical Trials Protocol Registration and Results (PRS) summary).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-11 |
What the finished NCT02525731 record still lists
NCT02525731 is an observational study that tracks outcomes without assigning an intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02525731 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02525731 about?
NCT02525731 is a clinical study titled "Targeting Effective Analgesia in Clinics for HIV - Patient Cohort". The TEACH patient cohort will characterize a clinic sample of HIV-infected patients on chronic opioid therapy (COT) by describing basic demographics and health status, including characteristics of pain (severity and interference), aberrant behaviors/misuse of COT, substance use and trust/satisfactio...
What is the current status of trial NCT02525731?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2015-07. Estimated completion is 2018-11.
Who is sponsoring clinical trial NCT02525731?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia